{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T01:14:45Z","timestamp":1776215685936,"version":"3.50.1"},"reference-count":20,"publisher":"American Diabetes Association","issue":"10","license":[{"start":{"date-parts":[[2016,9,22]],"date-time":"2016-09-22T00:00:00Z","timestamp":1474502400000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association Midwest Affiliate","doi-asserted-by":"publisher","award":["15GRNT25250015"],"award-info":[{"award-number":["15GRNT25250015"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,10,1]]},"DOI":"10.2337\/dbi16-0042","type":"journal-article","created":{"date-parts":[[2016,9,22]],"date-time":"2016-09-22T15:38:26Z","timestamp":1474558706000},"page":"2832-2834","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":35,"title":["Hydrogen Sulfide Therapy in Diabetes-Accelerated Atherosclerosis: A Whiff of Success"],"prefix":"10.2337","volume":"65","author":[{"given":"William","family":"Durante","sequence":"first","affiliation":[{"name":"Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia, MO"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2016,9,15]]},"reference":[{"key":"2026041420323272300_B1","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/CIRCULATIONAHA.116.022194","article-title":"Clinical update: cardiovascular disease in diabetes mellitus. Atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus \u2013 mechanisms, management, and clinical considerations","volume":"133","author":"Low Wang","year":"2016","journal-title":"Circulation"},{"key":"2026041420323272300_B2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2337\/db15-1003","article-title":"Gasotransmitters in vascular complications of diabetes","volume":"65","author":"van den Born","year":"2016","journal-title":"Diabetes"},{"key":"2026041420323272300_B3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.niox.2013.07.002","article-title":"Hydrogen sulfide chemical biology: pathophysiological roles and detection","volume":"35","author":"Kolluru","year":"2013","journal-title":"Nitric Oxide"},{"key":"2026041420323272300_B4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.freeradbiomed.2013.02.024","article-title":"Microbial regulation of host hydrogen sulfide bioavailability and metabolism","volume":"60","author":"Shen","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"2026041420323272300_B5","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/CIRCRESAHA.114.300505","article-title":"Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease","volume":"114","author":"Polhemus","year":"2014","journal-title":"Circ Res"},{"key":"2026041420323272300_B6","doi-asserted-by":"crossref","first-page":"ra72","DOI":"10.1126\/scisignal.2000464","article-title":"H2S signals through protein S-sulfhydration","volume":"2","author":"Mustafa","year":"2009","journal-title":"Sci Signal"},{"key":"2026041420323272300_B7","doi-asserted-by":"crossref","first-page":"13829","DOI":"10.1073\/pnas.1105121108","article-title":"Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function","volume":"108","author":"Suzuki","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026041420323272300_B8","doi-asserted-by":"crossref","first-page":"28827","DOI":"10.1074\/jbc.M114.596593","article-title":"Hydrogen sulfide alleviates diabetic nephropathy in a streptozotocin-induced diabetic rat model","volume":"289","author":"Zhou","year":"2014","journal-title":"J Biol Chem"},{"key":"2026041420323272300_B9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/bph.12163","article-title":"Treatment with hydrogen sulfide alleviates streptozotocin-induced diabetic retinopathy in rats","volume":"169","author":"Si","year":"2013","journal-title":"Br J Pharmacol"},{"key":"2026041420323272300_B10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1042\/CS20140460","article-title":"Hydrogen sulfide attenuates the development of diabetic cardiomyopathy","volume":"128","author":"Zhou","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"2026041420323272300_B11","article-title":"Hydrogen sulfide induces Keap1 S-sulfhydration and suppresses diabetes-accelerated atherosclerosis via Nrf2 activation","author":"Xie","journal-title":"Diabetes 2016;65:3171\u20133184"},{"key":"2026041420323272300_B12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.redox.2012.10.001","article-title":"The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer","volume":"1","author":"Kansanen","year":"2013","journal-title":"Redox Biol"},{"key":"2026041420323272300_B13","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/bjp.2008.296","article-title":"Biosynthesis of H2S is impaired in non-obese diabetic (NOD) mice","volume":"155","author":"Brancaleone","year":"2008","journal-title":"Br J Pharmacol"},{"key":"2026041420323272300_B14","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1089\/ars.2009.2956","article-title":"Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation?","volume":"12","author":"Jain","year":"2010","journal-title":"Antioxid Redox Signal"},{"key":"2026041420323272300_B15","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1007\/s00125-010-1761-5","article-title":"Adiposity is a major determinant of plasma levels of the novel vasodilator hydrogen sulphide","volume":"53","author":"Whiteman","year":"2010","journal-title":"Diabetologia"},{"key":"2026041420323272300_B16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.freeradbiomed.2015.06.019","article-title":"Role of Nrf2 in the pathogenesis of atherosclerosis","volume":"88","author":"Mimura","year":"2015","journal-title":"Free Radic Biol Med"},{"key":"2026041420323272300_B17","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.2337\/db13-1743","article-title":"Derivative of bardoxolone methyl, Dh404, in an inverse dose-dependent manner lessens diabetes-associated atherosclerosis and improve diabetic kidney disease","volume":"632","author":"Tan","year":"2014","journal-title":"Diabetes"},{"key":"2026041420323272300_B18","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.2741\/3860","article-title":"Protective role of heme oxygenase-1 against inflammation in atherosclerosis","volume":"16","author":"Durante","year":"2011","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2026041420323272300_B19","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1161\/CIR.0000000000000343","article-title":"Sex differences in the cardiovascular consequences of diabetes mellitus: a scientific statement by the American Heart Association","volume":"132","author":"Regensteiner","year":"2015","journal-title":"Circulation"},{"key":"2026041420323272300_B20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1039\/C3MD00362K","article-title":"Hydrogen sulfide donors in research and drug development","volume":"5","author":"Song","year":"2014","journal-title":"MedChemComm"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/diabetes.diabetesjournals.org\/syndication\/doi\/10.2337\/dbi16-0042","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/65\/10\/2832\/581361\/dbi160042.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/65\/10\/2832\/581361\/dbi160042.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:32:41Z","timestamp":1776213161000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/65\/10\/2832\/35019\/Hydrogen-Sulfide-Therapy-in-Diabetes-Accelerated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,15]]},"references-count":20,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,9,15]]},"published-print":{"date-parts":[[2016,10,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dbi16-0042","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,15]]}}}